On October 15, 2020 Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), reported that it has been invited to participate in the Cancer Innovation Summit (Press release, PLUS THERAPEUTICS, OCT 15, 2020, View Source [SID1234572293]). The meeting, which is hosted by Health Tech Austin, is being held virtually on Thursday, October 22 from 12.00 to 3.00 p.m. EDT.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Gregory Stein, M.D., Senior Vice President of Clinical Development at Plus Therapeutics will present as part of the Cancer Drug Showcase, which features novel cancer technologies from across the industry.

Register for the meeting webcast here: View Source

The Cancer Innovation Summit brings together thought leaders and innovators to share knowledge, experience, research and insights about cancer innovation.